Topics

Low levels of chemical that’s been linked to cancer discovered in Zantac

18:39 EDT 13 Sep 2019 | Vitals on NBC News

The FDA issued an alert that Zantac and its generic versions contain low levels of a probable human carcinogen called NDMA, but it is not calling for individuals to stop taking the drug as the agency continues to investigate.

Original Article: Low levels of chemical that’s been linked to cancer discovered in Zantac

NEXT ARTICLE

More From BioPortfolio on "Low levels of chemical that’s been linked to cancer discovered in Zantac"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...